Rakovina Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Mads Daugaard
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.2% |
| Management average tenure | no data |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO
Mads Daugaard
no data
Tenure
Dr. Mads Daugaard serves as the President, Chief Executive Officer and Chief Scientific Officer at Rakovina Therapeutics Inc. Dr. Daugaard is a recognized world leader in the field of translational cancer...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 3.3yrs | CA$120.00k | 2.6% CA$ 200.5k | |
| Member of Scientific Advisory Board | 3.3yrs | no data | no data | |
| Independent Director | 3.3yrs | CA$42.50k | no data | |
| Chairman of Scientific Advisory Board & Independent Director | 3.3yrs | CA$35.00k | 0.89% CA$ 68.8k | |
| Independent Director | 5.2yrs | CA$39.00k | 7.17% CA$ 552.7k | |
| Senior AI | less than a year | no data | no data | |
| Member of Scientific Advisory Board | 3.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.3yrs | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
3.3yrs
Average Tenure
64yo
Average Age
Experienced Board: RKV's board of directors are considered experienced (3.3 years average tenure).